精準納米CTC早期癌症篩查 | 美亞生命科技顧問有限公司 HKLSC

CTC Precision Cancer Cell Detection Service

BACK

What is CTC Precision Cancer Cell Detection?

CTC cancer cell detection evaluates the quantity and type of cancer cells through a blood sample, assessing cancer risk and progression. Leveraging their proprietary "liquid biopsy" technology, CTC detects subtle cancer indicators with just a small blood draw, enabling early detection and prevention. This technology is non-invasive, safe, cost-effective, minimizes wait times, and offers high sensitivity and accuracy, eliminating the risks and inconveniences associated with traditional live tissue biopsy. It also integrates "semiconductor biomedical chips" and "A.1 AI-assisted judgment" technology developed in-house, capable of detecting rare target cells in blood and applicable for genetic and protein research to assist physicians in tailoring personalized treatment plans.

Reasons for Choosing CTC Precision Cancer Cell Detection Service

Blood Sample : CTC testing requires only a small blood sample, making the process simple, fast, and minimally discomforting, avoiding the need for surgical procedures and associated risks of traditional tissue biopsies.
Patient Comfort : With a straightforward blood draw, patients experience minimal physical discomfort or psychological stress, suitable for a broad range of individuals, including those unable to tolerate invasive procedures.
High Sensitivity : CTC testing detects minute quantities of tumor cells in blood, aiding in early-stage cancer detection, even identifying tiny metastases.
Timely Intervention : Early cancer detection allows for prompt treatment intervention, crucial for improving treatment outcomes and patient survival rates.
Continuous Monitoring : CTC testing can be conducted repeatedly, facilitating ongoing monitoring of disease progression, particularly beneficial during treatment.
Assessing Treatment Efficacy : Regularly monitoring changes in CTC counts enables doctors to assess treatment effectiveness and make timely adjustments to treatment plans.
Targeted Therapy : Analyzing CTC molecular characteristics provides detailed tumor information, aiding in the development of personalized treatment strategies.
Prognostic Prediction : CTC quantity and characteristics predict patient prognosis, serving as a basis for long-term treatment planning.
Advanced Technology : Utilizing cutting-edge isolation and detection techniques, CTC testing delivers highly accurate and reliable results.
Professional Analysis : Results are analyzed and interpreted by experienced professionals, ensuring accuracy and clinical significance.
Variety of Cancers : CTC testing is applicable to multiple cancer types, including but not limited to breast, lung, colon, prostate, and pancreatic cancers.
Versatility : Whether for initial diagnosis, post-operative follow-up, or recurrence monitoring, CTC testing provides valuable insights.

Process of CTC Precision Cancer Cell Detection Service

Blood Sample Extraction : A small amount of blood is drawn from the patient's arm vein.
Sample Processing : Specialized techniques isolate circulating tumor cells (CTCs) from blood.
CTC Detection and Counting : CTCs are detected and counted using microscopy or automated equipment.
Data Analysis and Reporting : Professionals analyze test results, generate reports, and provide diagnosis and treatment recommendations.

Advantages of "HKLSC" in CTC Precision Cancer Cell Detection

"HKLSC" CTC Precision Cancer Cell Detection service is developed in collaboration with a technology company based in Taiwan, renowned for advanced image recognition technology applied in cellular image analysis. Through image processing and machine learning, this technology accurately identifies and analyzes cell characteristics and behaviors, delivering faster and more precise diagnostic outcomes. It was also honored with the CES Innovation Award, a prestigious recognition in global consumer electronics in 2023.

CTC Precision Cancer Cell Detection Q&A

Why use a biochip to capture cancer cells?

Capturing over a hundred million cells in blood requires high capture efficiency, especially when dealing with just a few cancer cells. Therefore, precise nano-level capture through advanced biochips is necessary for accurate detection, hence termed positive screening.

How are cancer cells captured?

Microfluidic channels etched onto the chip direct blood flow, utilizing specific antigen antibodies to ensure cancer cells are effectively captured without evasion.

How are cancer cells distinguished?

Normal and cancer cells differ in terms of nucleus size, cell shape, nuclear membrane analysis, and antigen and protein expression. However, manual identification is nearly impossible, making AI-powered analysis more precise.

Where does AI obtain its samples?

Supervised learning involves gathering data from over tens of thousands of samples. Our database, collected from blood samples over 5 years of IRB-approved clinical trials, is among the largest in the industry and this field.

How long does it take to analyze a specimen?

Analysis is typically completed within 3 to 5 minutes, compared to traditional methods which often take over 8 hours and are less accurate. Data is then uploaded to our database for further analysis.

Is the instrument certified?

The Cell Reveal Rare Cell Extraction Device holds Taiwan's Ministry of Health and Welfare's IVD certification for medical equipment.

Differences in Equipment Compared to Others?

Both hardware and software are independently developed, integrating global ICT information and communication technology with artificial intelligence and biotechnology, a capability unique to MediLink.

Distinguishing Features of the Report?

Reports from other providers typically indicate the number of cancer cells per 1 cc of blood, merely alerting individuals to their risk. For MediLink, this represents the basic level. We can further differentiate whether the tumor is malignant, nodular, or benign. We can predict the primary source of cancer, determine if there is metastasis (sometimes not visible on imaging), and use various data to advise on targeted therapy and immunotherapy. Immunotherapy is not an optimal screening tool, as its efficacy can vary at different stages, but through blood testing, we can determine the appropriate timing. We can isolate specific cells for genetic analysis, pinpoint their mutation sites using XY-axis robotic arms, and trace their origins in a database.

Purpose of Nanocancer Screening Precision Testing?

Cancer is the second leading cause of death among Chinese residents. When detected early, the cure rate can reach 70% to 90%, whereas in middle to late stages, it drops to only 10% to 30%. Therefore, the key to preventing tumors lies in early detection and diagnosis before symptoms appear, enabling early treatment opportunities.
Early screening is the most effective way to prevent tumors. Health examinations and cancer screenings include CT scans, MRIs, ultrasounds, tumor markers for both men and women, as well as virus antibodies and genetic testing related to tumor triggers. Early detection and prevention through health check-ups are the true guardians of cancer prevention.
The goal is for everyone to be healthy through testing. If cancer cells are detected, we aim to assess the risk at stage 0, rather than waiting until stages III or IV for detection, emphasizing prevention over delayed awareness.

Basic Functions of Nanocancer Screening Precision Testing:

Early determination of malignancy.
Predetermined site detection.